EUVIMEDEUVIMED entdecken
Crossref

Allosteric Activation of SIRT1 by 2,4-Dihydroxy-azaflavanone Averts MPP + -Mediated Dysfunction in Mitochondrial Biogenesis and Bioenergetics: Implications for Parkinson’s Disease

Chitrakshi Pant, Genji Sukumar, Vidya Jyothi Alli, Surender Singh Jadav iD, Srihari Pabbaraja iD, Shasi V Kalivendi iD

ACS Chemical Neuroscience · 2024

DOI: 10.1021/acschemneuro.4c00244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Chitrakshi Pant und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Hyderabad 500007, India. Hauptthemen laut MEDLINE: Sirtuin 1, Mitochondria, Flavanones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a complex neurodegenerative disorder that affects dopamine neurons of the substantia nigra pars compacta (SNpc), resulting in motor dysfunction. Among the pathways examined, mitochondria and α-synuclein were found to play a major role in the disease progression. Hence, several attempts are being made to restore mitochondrial bioenergetics or protein aggregation pathways as disease-modifying strategies. Our earlier studies reported the protective effect of 2,4-dihydroxy-azaflavanone (azaflavanone) in a transgenic Drosophila fly model of PD. In the present study, we found that azaflavanone acts as an allosteric activator of SIRT1 in both cell-free and cell-based systems and the effects were more pronounced as compared to resveratrol. Also, azaflavanone appears to interact selectively with SIRT1 as other SIRTs such as SIRT3 and SIRT6 did not exhibit any gross changes in cellular thermal shift assay (CETSA). Molecular docking studies depicted a higher docking score with azaflavanone than with resveratrol. Further, N27 cells treated with azaflavanone exhibited a dose-dependent increase in the mitotracker staining, mtDNA/nuclear DNA ratio, and also mitochondrial bioenergetics. The observed effects appear to be due to the activation of SIRT1, as evidenced by an increase in the expression of PGC-1α and TFAM, which are the downstream targets of SIRT1. Lastly, the Parkinsonian mimic MPP+-induced disturbance in the mitochondrial membrane potential, mitochondrial bioenergetics, and biogenesis were ameliorated by azaflavanone. Overall, our findings indicate that azaflavanone, being an antioxidant and an allosteric activator of SIRT1, is a promising compound for ameliorating the pathophysiology of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1MitochondriaFlavanonesAnimalsParkinson DiseaseAllosteric RegulationEnergy MetabolismMolecular Docking SimulationOrganelle Biogenesis1-Methyl-4-phenylpyridiniumRatsResveratrolHumans

Stichwörter der Autor:innen

Parkinson’s diseaseSIRT1azaflavanonebioenergeticsbiogenesismitochondria

Substanzen

Sirtuin 1Flavanones1-Methyl-4-phenylpyridiniumResveratrol

Autor:innen und Institutionen

  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Hyderabad 500007, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Department of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology, Uppal Road, Hyderabad 500007, India.
  • Department of Chemistry, Adikavi Nannaya University, Rajamahendravaram, AP 533296, India.
  • Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Uppal Road, Hyderabad 500007, India.

ORCID-Profile: Surender Singh Jadav, Srihari Pabbaraja, Shasi V Kalivendi

Förderung

  • Council of Scientific and Industrial Research, India

Zitieren

APA

Pant, C., Sukumar, G., Alli, V. J., Jadav, S. S., Pabbaraja, S., & Kalivendi, S. V. (2024). Allosteric Activation of SIRT1 by 2,4-Dihydroxy-azaflavanone Averts MPP + -Mediated Dysfunction in Mitochondrial Biogenesis and Bioenergetics: Implications for Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00244

Vancouver

Pant C, Sukumar G, Alli VJ, Jadav SS, Pabbaraja S, Kalivendi SV. Allosteric Activation of SIRT1 by 2,4-Dihydroxy-azaflavanone Averts MPP + -Mediated Dysfunction in Mitochondrial Biogenesis and Bioenergetics: Implications for Parkinson’s Disease. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00244

BibTeX
@article{Pant2024,
  author = {Pant, Chitrakshi and Sukumar, Genji and Alli, Vidya Jyothi and Jadav, Surender Singh and Pabbaraja, Srihari and Kalivendi, Shasi V},
  title = {Allosteric Activation of SIRT1 by 2,4-Dihydroxy-azaflavanone Averts MPP + -Mediated Dysfunction in Mitochondrial Biogenesis and Bioenergetics: Implications for Parkinson’s Disease},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  doi = {10.1021/acschemneuro.4c00244}
}
Kostenlos starten →